Purchase Eleview® in the US through the Aries network of common medical supply distributors.

Purchasing Eleview® submucosal injection agent in the United States
Box of Eleview® with ampoules

Ordering options and support for Eleview®.

Distributor ordering for Eleview® submucosal injection agent

Distributors

Order Eleview® via our network of distributors. Download this trade sheet for assistance in placing your order.

Image of Eleview® Distributor Trade Sheet for ordering assistance

Third-party ordering Eleview® submucosal injection agent

Third-party suppliers

Order Eleview® via a third-party supplier. Download this trade sheet for assistance in placing your order.

Image of Eleview® Third-party Trade Sheet for ordering assistance

Dept. of Veteran Affairs & Dept. of Defense ordering Eleview® submucosal injection agent

Dept. of Veteran Affairs & Dept. of Defense

Order Eleview® via the Dept. of Veteran Affairs or Dept. of Defense. Download this trade sheet for assistance in placing your order.

Image of Eleview® Dept. of Veteran Affairs & Dept. of Defense Trade Sheet for  ordering assistance

Billing and Coding Reimbursement Guide for Eleview®

Billing and Coding Guide

The Eleview® Billing and Coding Guide assists hospitals and physicians with general coding, coverage, and payment information when submitting claims for gastrointestinal endoscopic procedures with Eleview®. Download the guide

Billing and Coding Reimbursement Guide for Eleview®

Customer service for Eleview® submucosal injection agent

Customer service inquiries

For questions, call 1-888-274-3708.

Image of Eleview® submucosal injection agent

Shipment Information

Shipment information for Eleview® submucosal injection agent

To protect the 10-mL ampoules from freezing or excessively high temperatures, Eleview® is shipped in a thermo-protective container with ambient gel packs and includes an irreversible descending temperature indicator.

GTIN (UDI) numbers for Eleview®

GTIN information for Eleview® submucosal injection agent

Package Level Description GTIN (UDI)
Base Unit Individual 10-mL ampoule 5391530190008
Inner Pack Folding box containing 1 foil pouch of 5 ampoules 5391530190015
Case Inner box containing 5 folding boxes 5391530190022
Case Outer box (contains 4 inner boxes) = 20 folding boxes 5391530190039

Manufacturing information for Eleview® submucosal injection agent

Manufacturing Information

Eleview® is manufactured and packaged by Cosmo Technologies Ltd in Dublin, Ireland, and imported and distributed by Aries Pharmaceuticals, Inc. in the United States.

INDICATIONS FOR USE

Eleview® submucosal injectable composition is intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers, or other gastrointestinal mucosal lesions, prior to excision with a snare or endoscopic device.

CONTRAINDICATIONS

Patients with known sensitivity to any of the components contained in Eleview®.

WARNINGS AND PRECAUTIONS

  • The endoscopist injecting Eleview® must be experienced in the administration technique.
  • The safety of Eleview® has not been established in pregnant or lactating women, or in children under 18 years of age.
  • Eleview® is provided in single-use ampoules. Eleview® should not be reused after the first opening. Any emulsion not injected during the procedure should not be reused for another endoscopic procedure.
  • Do not use if the primary packaging (ampoule) or secondary packaging (aluminum pouch) is damaged.
  • Do not use if the twist-off cap is damaged.
  • Do not use if the emulsion is not clear, shows any signs of opalescence, or contains floating or precipitated visible particles.
  • The product compatibility with other substances has not been tested.

ADVERSE REACTIONS

Rarely, local bleeding and/or inflammatory reaction could occur which may or may not be associated with Eleview®.

DOSAGE AND ADMINISTRATION

The administered dose of Eleview® should be determined based on the dimensions of the lesion to be removed. Inject into the submucosa the amount of Eleview® needed to form a submucosal cushion of optimal height and shape for the lesion to be removed. During the procedure do not exceed a total dose of 50 mL per patient, either in single or in multiple administrations.

Please see Instructions for Use for complete Important Safety Information.